Search
Neither shots nor pills will immunize smaller medical, dental, chiropractic, and physical therapy practices, surgery centers, and other healthcare concerns from compliance with the looming (and burdensome) reporting obligations imposed on them if they are “reporting companies” under the federal...
Final regulations published on September 30, 2022 (the “final Regulations”) by the Financial Crimes Enforcement Network (“FinCEN”) of the Department of Treasury under the Corporate Transparency Act (“CTA”) grant business owners a reprieve, but not a pardon, with respect to their looming beneficial...
Kathryn Doyle, Partner at Saul Ewing LLP, will be presenting at the NACUA Annual Meeting, June 26-29, 2022, in Pittsburgh. She will be speaking on June 28, 9:15-10:30 a.m., on the topic "You Thought You Owned It, They Might Have Stolen It, and a Medley of Inventor Kerfuffles”. Joining Kathryn will...
Marshall Paul focuses his practice on counseling businesses, health care concerns and professionals with respect to limited liability company matters, general corporate matters, joint ventures, acquisitions and sales, fiduciary duty issues and financings. His clients include large-scale health care...
Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...
Jessica Lenoir, Ph.D., helps clients protect their intellectual property by drafting patent applications and preparing office action responses to the U.S. Patent and Trademark Office and foreign offices. In handling this work, Jessica draws on her knowledge from earning a doctorate in...
A key component of a company’s intellectual property strategy is the protection of its industrial designs, including the ornamental features of products, graphical user interfaces, icons and fonts, to combat competitors copying its products. Industrial design protection fills a niche between (and...
The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...
Patrick Rodriguez's practice focuses on business and tax planning law. A certified public accountant, Patrick is experienced in representing clients in mergers and acquisition. He represents both buyers and sellers in a broad range of transactions, which encompasses stock purchases and asset sales...
Tom Murray is a patent agent who helps clients protect their intellectual property through patent preparation and prosecution, as well as analyses involving freedom to operate, non-infringement and invalidity. Tom also has experience with matters involving post-grant prosecutions. His IP work for...
Andrew Schwerin represents clients in patent and trade secret litigation on both the plaintiff and defense sides of these disputes. Outside of his litigation work, Andrew counsels clients on their IP strategy. Andrew has represented clients in connection with a range of technologies including...
Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...